Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway

Osteosarcoma (OS) is the most common malignancy of bone. Liensinine exerts antitumor effects on cancers of the colon, breast, and gallbladder. However, its antitumor activity in OS remains unclear. This study is aimed at investigating the efficacy of liensinine against OS and the underlying mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Fei, Liu, Yu, Dou, Xinyu, Du, Chuanchao, Mao, Tianli, Liu, Xiaoguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807040/
https://www.ncbi.nlm.nih.gov/pubmed/35116094
http://dx.doi.org/10.1155/2022/8245614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807040/
https://www.ncbi.nlm.nih.gov/pubmed/35116094
http://dx.doi.org/10.1155/2022/8245614

Ejemplares similares